SERIES F COMMON STOCK PURCHASE WARRANT RESHAPE LIFESCIENCES INC.ReShape Lifesciences Inc. • September 30th, 2019 • Electromedical & electrotherapeutic apparatus
THIS SERIES F COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from ReShape Lifesciences Inc., a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SERIES E COMMON STOCK PURCHASE WARRANT RESHAPE LIFESCIENCES INC.ReShape Lifesciences Inc. • September 30th, 2019 • Electromedical & electrotherapeutic apparatus
THIS SERIES E COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five year anniversary of the Reverse Stock Split Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from ReShape Lifesciences Inc., a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • September 30th, 2019 • ReShape Lifesciences Inc. • Electromedical & electrotherapeutic apparatus
This Warrant Exercise Agreement (this “Agreement”), dated as of September 23, 2019, is by and between ReShape Lifesciences Inc., a Delaware corporation (the “Company”), and the undersigned holder (each, a “Holder” and, collectively, the “Holders”) of Series B Common Stock Purchase Warrants to purchase shares of common stock of the Company, $0.01 par value per share (the “Common Stock”), at an exercise price of $0.02 per share, with a term of one year following the effectuation of a reverse stock split by the Company (the “Original Warrants”). The Original Warrants were issued pursuant to that certain Securities Purchase Agreement, dated as of June 13, 2019, between the Company the purchasers party thereto (the “SPA”).
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 30th, 2019 • ReShape Lifesciences Inc. • Electromedical & electrotherapeutic apparatus
